Science
Mechanism of Action
Isoeugenol operates as an antioxidant and anti-inflammatory agent, potentially engaging NRF2 signaling pathways. Its antimicrobial action primarily involves destabilizing bacterial cell membranes and inhibiting vital metabolic enzymes, leading to cellular compromise. Crucially, as a skin sensitizer, isoeugenol acts as a prehapten; it undergoes enzymatic activation or oxidation within the epidermis, forming highly reactive intermediates like hydroxy quinone methides (HQM) that covalently bind to skin proteins, triggering an allergic immune response.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Concentrations of 0.5%, 1.5%, and 2.5% in creams exhibited strong inhibitory effects against various Gram-positive bacterial strains (e.g., Staphylococcus aureus, Enterococcus faecalis) and yeast-like microorganisms (e.g., Candida albicans), indicating antibacterial, antifungal, anti-inflammatory, and antioxidant properties.
Transparency
Dusting Analysis
Isoeugenol's purported active benefits (antimicrobial, antioxidant) are observed at concentrations (0.5% to 2.5%) that are significantly above both the maximum permitted concentration in ready-for-use products (0.02%) and the thresholds requiring declaration on ingredient lists (0.001% in leave-on products). Its inclusion in cosmetics is primarily for fragrance at trace levels, not for active treatment, yet still carries a substantial sensitization risk.
The Formula
Formulation
Stability
Isoeugenol is prone to rapid oxidation, particularly under photo-induced conditions. This oxidation generates reactive intermediates that increase its potential for skin sensitization. Initially a colorless oil, it may become yellow and viscous with extended storage.
Safety
Safety Profile
The International Fragrance Association (IFRA) recommends concentrations below 0.02% (200 ppm) in final products due to its moderate to high skin sensitizing potential. The EU Cosmetics Regulation 1223/2009 lists it as a restricted ingredient (Annex III/73), mandating its presence to be indicated on the ingredient list if concentrations exceed 0.001% in leave-on products and 0.01% in rinse-off products. Clinical studies have shown mild irritation at 2% and moderate irritation at 32% under occlusion. More concerningly, sensitization was observed in 63% of subjects at 0.2% and a minimum effect level for sensitization was below 0.01% in 20% of subjects. Safe Work Australia classifies Isoeugenol as hazardous for 'Skin sensitisation—category 1' ('May cause an allergic skin reaction'), 'Skin Irritation—Category 2', 'Eye Irritation—Category 2A', 'Acute Toxicity – Category 4', and 'Carcinogenicity – Category 2'.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Isoeugenol is a potent skin sensitizer and irritant, making it unsuitable for inclusion in precision skincare formulations. While INCIDecoder indicates it is not problematic for 'sensitive' skin, this contradicts extensive clinical data demonstrating a high risk of sensitization and irritation even at very low concentrations. Its purported benefits, such as antioxidant and antimicrobial activity, are observed at concentrations (0.5-2.5%) that vastly exceed the strict regulatory safety limits (maximum 0.02%) and known thresholds for allergic reactions, rendering any active use problematic and hazardous.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources